A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10-60 Years Following Essen and Zagreb Vaccination Procedures
Release Time:2024-07-02 Hits:
Indexed by: Journal Papers
Document Code: 373393
Date of Publication: 2023-08-18
Journal: VACCINES
Volume: 11
Issue: 8
Key Words: ADULTS; CHINA; POSTEXPOSURE PROPHYLAXIS; PVRV; REGIMEN; SERUM-FREE